首页 | 本学科首页   官方微博 | 高级检索  
     

鸡马立克氏病CVI988/Rispens疫苗免疫效力试验
引用本文:周煜,李汉秋. 鸡马立克氏病CVI988/Rispens疫苗免疫效力试验[J]. 河南畜牧兽医(综合版), 2000, 0(1): 7-8
作者姓名:周煜  李汉秋
作者单位:北京市农林科学院畜牧兽医研究所(周煜,周蛟,苏凤林),北京翎羽禽病防治技术开发有限公司(李汉秋,林健,管艺)
摘    要:应用荷兰农业部提供的鸡马立克氏病(MD)CVI988/Rispens Ⅰ型致弱种毒, 在农业部批准的符合GMP 要求的生产车间研制出鸡马立克氏病CVI988/Rispens 疫苗。将按国际标准检验合格的三批疫苗及进口商品CVI988/Rispens 疫苗接种1 日龄SPF 雏鸡, 于7 日龄经腹腔攻击鸡马立克氏病强毒(北京- 1 株) 血毒, 全部鸡只隔离饲养观察至60 日龄并作全群剖检。经测定: 非免疫攻毒组100% 发病,健康对照组全部阴性, 三批国产CVI988/Rispens 疫苗保护指数分别为90-0, 90-0, 93-3 , 进口商品苗保护率为93-3 。结果表明国产和进口CVI988/Rispens疫苗均能提供对MD 较高的免疫保护力, 国产疫苗的保护效果达到了国际同类产品的先进水平。

关 键 词:鸡马立克氏病  免疫效力  疫苗  CVI988/Rispens

Experimental Tests of Efficacy of Marek's Disease Vaccine (CVI988/Rispens)
Zhou Yu et al.. Experimental Tests of Efficacy of Marek's Disease Vaccine (CVI988/Rispens)[J]. Henan Journal of Animal Husbandry and Veterinary Medicine, 2000, 0(1): 7-8
Authors:Zhou Yu et al.
Abstract:Marek's Disease(MD)vaccine(CVI988/Rispens)developed and produced domestically by the use of the intvoduced Seed Virus of serotype I vaccine strain CVI988/Rispens from the Netherlands was tested for its efficacy.1-day-old SPF chickens were vaccinated with 3 batches(003,008and 010)of the home-grown vaccines and 1batch of the commercial product imported.Challenge was done at 7 days post-vaccination using the blood virus of very virulent MD virus(strain J-1).The protection indices(PI) obatainded at 60 days of age were 90 0,90 0,93 3and 93 3 respectively.The results showed that all the vaccines(CVI988/Rispens)of the two different sources provided high rate of protection against the vMDV.
Keywords:Marek's  Disease  efficacy  vaccine  CVI988/Rispens
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号